NCT00358553已完成1 期
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, and safety of recombinant human insulin. The study will consist of 2 phases.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy Male Subjects
- •Age between 18 and 40 years of age
排除标准
- •History of Diabetes
- •Subjects with clinically significant active disease
- •Known allergy to insulin
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/RiastapCongenital Fibrinogen DeficiencyAfibrinogenemiaNCT01575756Octapharma22
Unknown
1 期
The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy AdultsHealthy VolunteersNCT05321732Daewoong Pharmaceutical Co. LTD.24
终止
1 期
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced DyskinesiaLevodopa-induced DyskinesiaNCT00607451Neurim Pharmaceuticals Ltd.8
招募中
1 期
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy AdultsDyslipidemiasType 2 DiabetesNCT06578676Hyundai Pharm56
已完成
1 期
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersHealthyNCT01415466Daewoong Pharmaceutical Co. LTD.36